BKM Wealth Management LLC Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

BKM Wealth Management LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CL) by 19.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,381 shares of the company’s stock after purchasing an additional 1,354 shares during the period. BKM Wealth Management LLC’s holdings in Colgate-Palmolive were worth $755,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Regal Investment Advisors LLC increased its position in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock worth $604,000 after acquiring an additional 121 shares in the last quarter. M&G Investment Management Ltd. grew its holdings in Colgate-Palmolive by 0.3% during the 4th quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock valued at $3,942,000 after purchasing an additional 125 shares in the last quarter. Wealthcare Advisory Partners LLC grew its holdings in Colgate-Palmolive by 3.9% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 3,404 shares of the company’s stock valued at $271,000 after purchasing an additional 127 shares in the last quarter. &PARTNERS grew its holdings in Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after purchasing an additional 129 shares in the last quarter. Finally, AMG National Trust Bank grew its holdings in Colgate-Palmolive by 0.4% during the 4th quarter. AMG National Trust Bank now owns 30,232 shares of the company’s stock valued at $2,410,000 after purchasing an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded down $0.75 during trading hours on Monday, hitting $96.29. 1,656,652 shares of the company traded hands, compared to its average volume of 4,483,908. The firm has a market cap of $79.00 billion, a P/E ratio of 30.78, a P/E/G ratio of 3.57 and a beta of 0.39. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The firm’s 50-day simple moving average is $93.87 and its two-hundred day simple moving average is $87.63. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $99.08.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company earned $0.73 EPS. As a group, analysts forecast that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.08%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, May 28th. Argus raised their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a report on Wednesday, May 15th. Stifel Nicolaus raised their price objective on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Barclays raised their price objective on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Finally, Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $93.83.

Insider Transactions at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.